Audience
Professionals interested in a solution to streamline the screening of scientific literature for safety-related information
About Compier Literature Screening
Compier Literature Screening is an AI-driven platform designed to assist pharmacovigilance professionals in efficiently screening abstracts, full texts, and translated articles to identify patients, authors, events, products, and safety-related information. The platform offers built-in integration with online biomedical databases such as Medline and supports bulk uploading of literature records from sources like Embase, conference presentations, and PDF journals. It performs automated duplicate checks for each literature search and utilizes validated AI models for automatic screening and annotation of entities. Users can configure scalable literature screening workflows tailored to specific requirements and global regulations. The system facilitates communication with third-party vendors to obtain full texts and includes built-in translation capabilities. It also integrates with safety systems, such as Oracle Argus Safety, to transmit ICSR-relevant articles.
Other Popular Alternatives & Related Software
PubMed
PubMed® comprises more than 35 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher websites. PubMed is a free resource supporting the search and retrieval of biomedical and life sciences literature with the aim of improving health–both globally and personally. The PubMed database contains more than 35 million citations and abstracts of biomedical literature. It does not include full text journal articles; however, links to the full text are often present when available from other sources, such as the publisher's website or PubMed Central (PMC). Citations in PubMed primarily stem from the biomedicine and health fields, and related disciplines such as life sciences, behavioral sciences, chemical sciences, and bioengineering. MEDLINE is the largest component of PubMed and consists primarily of citations from journals selected for MEDLINE.
Learn more
Dialog
Dialog offers a modular, end-to-end pharmacovigilance literature monitoring solution that supports organizations tasked with drug safety reporting by streamlining and automating the entire literature triage process. It provides access to over 140 authoritative scientific and medical literature databases, such as MEDLINE, Embase, and Biosis, standardizing content across sources to ensure consistent precision search, deduplication, and structured XML output. The DialogML engine employs artificial intelligence to rank search results by patient-safety relevance, highlight key safety concepts, and tag references related to ICSRs (Individual Case Safety Reporting), aggregate reports (PBRER, PSUR, DSUR), and safety signals, so reviewers can rapidly identify high-priority articles. The Dialog Alerts Manager simplifies alert creation and management, offering bulk editing, audit trails of search strategy changes, scheduling flexibility, and delivery history tracking.
Learn more
DF Literature Monitor
DF Literature Monitor is an advanced AI-powered solution designed to automate the monitoring of vast amounts of literature and optimize safety vigilance processes. It integrates with major global and local literature sources for simultaneous article retrieval, employing semantic search to identify relevant articles efficiently. The platform features automatic de-duplication, extraction of minimum safety information, and auto-population of safety case forms, which can be submitted to safety databases in E2B or Excel/PDF formats with a single click. Additionally, it offers automated translation of abstracts and full articles into English. DF Literature Monitor includes configurable workflows to facilitate collaboration and quality control among pharmacovigilance teams. By leveraging this solution, teams can save up to 60% or more time and effort in the literature monitoring process while ensuring quality and compliance.
Learn more
CoVigilAI
CoVigilAI is an AI-enabled medical literature monitoring solution that employs advanced algorithms and data analytics to proactively detect and manage adverse drug events, ensuring patient safety and regulatory compliance in real time. The platform offers streamlined tracking of scientific and medical publications across prominent global literature databases such as PubMed and Embase, with customizable search strings facilitating an effortless pharmacovigilance literature monitoring journey. Periodic surveillance of scientific and medical literature databases and publications from diverse local journals is conducted, encompassing both global literature monitoring and localized literature surveillance. Advanced algorithms categorize Individual Case Safety Reports (ICSRs) into valid, potential, and invalid cases, while automated key entity detection efficiently recognizes crucial entities like patients, medications, adverse events, and designated medical events.
Learn more
Integrations
Company Information
Techsol Life Sciences
Founded: 2010
Techsol Life Sciences
www.techsollifesciences.com/pharmacovigilance/compier-literature-screening/
Videos and Screen Captures
Other Useful Business Software
$300 Free Credits to Build on Google Cloud
Put your $300 in credit toward real workloads, then keep building with free monthly usage for 20+ products. No commitment and no charge until you upgrade.
Product Details
Platforms Supported
Cloud
Training
Documentation
Live Online
In Person
Support
Phone Support
24/7 Live Support
Online
